Shareholding disclosure

BNP PARIBAS SA

Declared position

5.83%

Threshold

Crossed upwards

Timeline

Published

08.04.2022

Transaction

05.01.2022

Voting rights breakdown

Voting rights acquired5.83%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAM4700037

Beneficial owner

BNP PARIBAS SA

Declared address

BNP PARIBAS SA, 75009 Paris

Rachat de titres pour restitution anticipée de titres empruntés

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

BNP PARIBAS SA

Vifor Pharma AG08.04.2022TAM4700037

Disclosure summary

BNP PARIBAS SA disclosed a holding in Vifor Pharma AG on the acquisition side, published by SIX Exchange Regulation on 08.04.2022, at 5.83% of voting rights. Notice category: Single shareholder.

Disclosed position

5.83%

Voting rights acquired

Voting rights acquired5.83%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

BNP PARIBAS SA disclosed a holding in Vifor Pharma AG, published on 08.04.2022.

Publication date08.04.2022

Transaction date05.01.2022

Issuing companyVifor Pharma AG

Beneficial ownerBNP PARIBAS SA

Declared addressBNP PARIBAS SA, 75009 Paris

CategorySingle shareholder

Voting rights acquired5.83%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAM4700037

Conditions

Rachat de titres pour restitution anticipée de titres empruntés

Source: SIX Exchange Regulation · Publication date: 08.04.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open